제대혈 처리 및 보존 장비 시장 : 유형, 치료 유형, 용도, 최종 사용자별 - 세계 예측(2025-2030년)

The Cord Blood Processing & Storage Equipment Market was valued at USD 298.61 million in 2023, expected to reach USD 354.20 million in 2024, and is projected to grow at a CAGR of 19.10%, to USD 1,015.25 million by 2030.

Cord blood processing and storage equipment are pivotal in the healthcare sector, facilitating the collection, processing, and preservation of stem cells from umbilical cord blood. These stem cells have become invaluable for treating various diseases and are crucial for advancements in regenerative medicine. The necessity of this equipment is underscored by its ability to store cord blood for future medical use as it is a rich source of hematopoietic stem cells, which are essential for treating blood-related diseases like leukemia and lymphoma. The primary application ranges from hospitals and research centers to specialized storage banks dedicated to maintaining these biological resources, with end-use predominantly in clinical treatments and research.

Market growth is being driven by increased awareness of the therapeutic potential of stem cells, rising incidences of genetic disorders, and technological advancements in stem cell preservation techniques. The expanding application of stem cells in regenerative medicine and personalized medicine also fuels demand. A blooming opportunity lies in the enhancement of cryopreservation and automation technologies, which are projected to mitigate human error and improve storage efficiency. Recommendations for businesses include investing in R&D to optimize cost-effectiveness and reliability of storage systems, expanding awareness campaigns to increase the public understanding of cord blood banking benefits, and forming alliances with healthcare institutions.

Nonetheless, market expansion faces challenges such as high operational costs, ethical concerns regarding stem cell research, and stringent regulatory frameworks that govern product approvals. Some geographical regions exhibit a lack of adequate infrastructure for storage and processing, limiting market penetration. Therefore, businesses can innovate by developing advanced, cost-efficient equipment with enhanced safety features that address regulatory concerns. The market's nature is highly competitive and dynamic, with innovation focusing on improving the reliability, accessibility, and efficiency of storage equipment, thus offering substantial opportunities for companies ready to navigate these complexities and invest strategically in research and partnerships.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cord Blood Processing & Storage Equipment Market

The Cord Blood Processing & Storage Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of genetic diseases
  • Government initiatives and growing clinical trials in regenerative medicines
  • Rising awareness about therapeutic applications of cord blood
• Market Restraints
  • High cost of processing and storage equipment
• Market Opportunities
  • Automated technology for cord blood banking
  • Expansion of public and private cord blood stem cell banking
• Market Challenges
  • Ethical and safety concerns associated with cord blood

Porter's Five Forces: A Strategic Tool for Navigating the Cord Blood Processing & Storage Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cord Blood Processing & Storage Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cord Blood Processing & Storage Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cord Blood Processing & Storage Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cord Blood Processing & Storage Equipment Market

A detailed market share analysis in the Cord Blood Processing & Storage Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cord Blood Processing & Storage Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cord Blood Processing & Storage Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cord Blood Processing & Storage Equipment Market

A strategic analysis of the Cord Blood Processing & Storage Equipment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cord Blood Processing & Storage Equipment Market, highlighting leading vendors and their innovative profiles. These include Americord Registry LLC, BioLife Solutions Inc., CBR Systems, Inc., Cordlife Group Ltd., Cryo-Cell International, Inc., Cryo-Save Group AV, Cryoviva Biotech Pvt. Ltd., FamiCord Group, Grifols, S.A., LifeCell International Pvt. Ltd., PerkinElmer Inc., Singapore Cord Blood Bank Limited, StemCyte Inc., Stirling Ultracold, Terumo Corp., ThermoGenesis Holdings, Inc., ViaCord, LLC, and Vita 34 AG.

Market Segmentation & Coverage

This research report categorizes the Cord Blood Processing & Storage Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Automated and Semi-Automated.
• Based on Treatment Type, market is studied across Anti-Rejection Drugs or Immunosuppressants, Antiviral Drugs, Chemotherapy Drugs, Corticosteroids, Immunoglobulins, Targeted Therapy, and Vaccines.
• Based on Application, market is studied across Anemia, Autism, Cerebral Palsy, Diabetes, Leukemia, and Thalassemia.
• Based on End-User, market is studied across Hospitals, Research Institutes, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of genetic diseases
    • 5.1.1.2. Government initiatives and growing clinical trials in regenerative medicines
    • 5.1.1.3. Rising awareness about therapeutic applications of cord blood
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of processing and storage equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Automated technology for cord blood banking
    • 5.1.3.2. Expansion of public and private cord blood stem cell banking
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical and safety concerns associated with cord blood
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cord Blood Processing & Storage Equipment Market, by Type

• 6.1. Introduction
• 6.2. Automated
• 6.3. Semi-Automated

7. Cord Blood Processing & Storage Equipment Market, by Treatment Type

• 7.1. Introduction
• 7.2. Anti-Rejection Drugs or Immunosuppressants
• 7.3. Antiviral Drugs
• 7.4. Chemotherapy Drugs
• 7.5. Corticosteroids
• 7.6. Immunoglobulins
• 7.7. Targeted Therapy
• 7.8. Vaccines

8. Cord Blood Processing & Storage Equipment Market, by Application

• 8.1. Introduction
• 8.2. Anemia
• 8.3. Autism
• 8.4. Cerebral Palsy
• 8.5. Diabetes
• 8.6. Leukemia
• 8.7. Thalassemia

9. Cord Blood Processing & Storage Equipment Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Research Institutes
• 9.4. Specialty Clinics

10. Americas Cord Blood Processing & Storage Equipment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cord Blood Processing & Storage Equipment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cord Blood Processing & Storage Equipment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Americord Registry LLC
• 2. BioLife Solutions Inc.
• 3. CBR Systems, Inc.
• 4. Cordlife Group Ltd.
• 5. Cryo-Cell International, Inc.
• 6. Cryo-Save Group AV
• 7. Cryoviva Biotech Pvt. Ltd.
• 8. FamiCord Group
• 9. Grifols, S.A.
• 10. LifeCell International Pvt. Ltd.
• 11. PerkinElmer Inc.
• 12. Singapore Cord Blood Bank Limited
• 13. StemCyte Inc.
• 14. Stirling Ultracold
• 15. Terumo Corp.
• 16. ThermoGenesis Holdings, Inc.
• 17. ViaCord, LLC
• 18. Vita 34 AG